STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Insulet Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Insulet Corporation (PODD) filed a Form 144 reporting a proposed sale of 797 common shares through Fidelity Brokerage Services LLC on the NASDAQ with an aggregate market value of $278,000.26. The filing shows the shares were acquired via options granted by the issuer on 02/28/2023 (541 shares) and 02/27/2024 (256 shares) and that payment is noted as cash with an approximate sale date of 09/08/2025. No securities were reported sold by the filer in the past three months. The filer attests they are unaware of any undisclosed material adverse information about the issuer.

Positive
  • Regulatory compliance: The filing provides required Rule 144 details including broker, share count, acquisition history, and aggregate value
  • Transparency: Broker name (Fidelity Brokerage Services LLC) and specific acquisition dates are disclosed, aiding investor clarity
Negative
  • None.

Insights

TL;DR: Routine insider sale notice; size is immaterial relative to outstanding shares, so limited market impact.

The Form 144 discloses a proposed disposition of 797 common shares with an aggregate market value of $278,000.26. Compared with the reported 70,392,535 shares outstanding, this represents a de minimis fraction and is unlikely to affect valuation or share supply materially. The shares were acquired via issuer-granted options, indicating the sale relates to option exercise or scheduled liquidation rather than a new external transaction. Filing completeness and broker identification (Fidelity Brokerage Services) support regulatory transparency.

TL;DR: Compliance-focused disclosure consistent with Rule 144; no governance red flags evident from this notice alone.

This Form 144 meets disclosure requirements by listing the broker, class, share count, aggregate value, acquisition dates, and nature of acquisition (issuer-granted options). The filer affirms no undisclosed material adverse information, which is a standard representation. Absent other filings or context (e.g., large clustered insider sales or related-party transactions), this single small-scale notice does not raise governance concerns.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Insulet's (PODD) Form 144 report?

The filing reports a proposed sale of 797 common shares through Fidelity with an aggregate market value of $278,000.26 and an approximate sale date of 09/08/2025.

How were the shares in the PODD Form 144 acquired?

The shares were acquired via issuer-granted options: 541 shares from an option granted 02/28/2023 and 256 shares from an option granted 02/27/2024.

Does the filing show recent sales by the same person?

No. The section for securities sold during the past three months states Nothing to Report.

Which broker will handle the sale in the PODD Form 144?

The broker listed is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield RI 02917, and the sale is to occur on NASDAQ.

What representation does the filer make about undisclosed information?

By signing, the filer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.
Insulet Corp

NASDAQ:PODD

PODD Rankings

PODD Latest News

PODD Latest SEC Filings

PODD Stock Data

22.50B
70.12M
0.27%
101.79%
2.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON